West Tower Group’s iShares Biotechnology ETF IBB Stock Holding History

West Tower Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,800	Closed	-$304K	–	57
2025 Q4	$304K	Buy	+1,800	New	+$292K	0.68%	32
2024 Q1	–	Sell	-690	Closed	-$93.7K	–	286
2023 Q4	$93.7K	Buy	+690	New	+$84.2K	0.19%	76

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

West Tower Group's IBB Position: Q1 2026 in Review

West Tower Group sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 1,800 shares — an estimated $304K sold.

West Tower Group first reported a position in IBB in Q4 2023 and held it in 2 quarters. The position peaked at $304K in Q4 2025. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

West Tower Group reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
West Tower Group sold 1,800 iShares Biotechnology ETF shares in Q1 2026, an estimated $304K.
West Tower Group first reported a position in iShares Biotechnology ETF in Q4 2023 and held it in 2 quarters.
West Tower Group's iShares Biotechnology ETF position peaked at $304K in Q4 2025.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on West Tower Group's 13F filing for Q1 2026, filed 29 Apr 2026.